Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News > Health News
Audio By Carbonatix
7:30 AM on Tuesday, December 23
The Associated Press
VAUGHAN, Ontario--(BUSINESS WIRE)--Dec 23, 2025--
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Executive Vice President and Chief Financial Officer Sam Eldessouky and Chief Medical Officer and Head of Research & Development Yehia Hashad, MD, will participate in a company presentation at the 44 th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 1:30 p.m. PT (4:30 p.m. ET).
A live webcast and audio archive of the event will be available on the Investor Relations page of the Bausch + Lomb website: http://ir.bausch.com/investors/events-presentations.
About Bausch + Lomb
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.
© 2026 Bausch + Lomb.
View source version on businesswire.com:https://www.businesswire.com/news/home/20251223765061/en/
CONTACT: Media Contact:
Chris Clark
(848) 360-1100Investor Contact:
George Gadkowski
(877) 354-3705 (toll free)
KEYWORD: NORTH AMERICA CANADA
INDUSTRY KEYWORD: RETAIL MEDICAL DEVICES HEALTH OTHER RETAIL GENERAL HEALTH OPTICAL
SOURCE: Bausch + Lomb Corporation
Copyright Business Wire 2025.
PUB: 12/23/2025 07:30 AM/DISC: 12/23/2025 07:30 AM
http://www.businesswire.com/news/home/20251223765061/en
